product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
NQO-1 Antibody (A180) - BSA Free
catalog :
NB200-209
quantity :
0.1 ml (also 0.025 ml)
price :
409 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
A180
reactivity :
human, mouse, rat, dogs
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, flow cytometry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section
more info or order :
citations: 51
Published Application/Species/Sample/DilutionReference
  • western blot; human; fig 7a
Moore T, Cheng L, Wolf D, Ngo J, Segawa M, Zhu X, et al. Parkin regulates adiposity by coordinating mitophagy with mitochondrial biogenesis in white adipocytes. Nat Commun. 2022;13:6661 pubmed publisher
Lapak K, Saeidi S, Bok I, Wamsley N, Plutzer I, Bhatt D, et al. Proximity proteomic analysis of the NRF family reveals the Parkinson's disease protein ZNF746/PARIS as a co-complexed repressor of NRF2. Sci Signal. 2023;16:eadi9018 pubmed publisher
Meister M, Feresin R. Blackberry consumption protects against e-cigarette-induced vascular oxidative stress in mice. Food Funct. 2023;14:10709-10730 pubmed publisher
Zarcone G, Lenski M, MARTINEZ T, Talahari S, Simonin O, Gar xe7 on G, et al. Impact of Electronic Cigarettes, Heated Tobacco Products and Conventional Cigarettes on the Generation of Oxidative Stress and Genetic and Epigenetic Lesions in Human Bronchial Epithelial BEAS-2B Cells. Toxics. 2023;11: pubmed publisher
Liu X, Yan C, Chang C, Meng F, Shen W, Wang S, et al. FOXA2 Suppression by TRIM36 Exerts Anti-Tumor Role in Colorectal Cancer Via Inducing NRF2/GPX4-Regulated Ferroptosis. Adv Sci (Weinh). 2023;10:e2304521 pubmed publisher
Wu D, Sun Q, Wei W, Bai Y, Zhai L, Jia L. Nrf2-mediated protective effect of alpha-lipoic acid on synaptic oxidative damage and inhibition of PKC/ERK/CREB pathway in bisphenol A-exposed HT-22 cells. Food Chem Toxicol. 2023;181:114112 pubmed publisher
Wamsley N, Wilkerson E, Guan L, Lapak K, Schrank T, Holmes B, et al. Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCC. Mol Cell Proteomics. 2023;22:100647 pubmed publisher
Wang X, Wang W, Zhang R, Ma B, Ni L, Feng H, et al. Melatonin attenuates high glucose‑induced endothelial cell pyroptosis by activating the Nrf2 pathway to inhibit NLRP3 inflammasome activation. Mol Med Rep. 2023;27: pubmed publisher
Meister M, Najjar R, Danh J, Knapp D, Wanders D, Feresin R. Berry consumption mitigates the hypertensive effects of a high-fat, high-sucrose diet via attenuation of renal and aortic AT1R expression resulting in improved endothelium-derived NO bioavailability. J Nutr Biochem. 2023;112:109225 pubmed publisher
Petrillo S, D Amico J, Nicita F, Torda C, Vasco G, Bertini E, et al. Antioxidant Response in Human X-Linked Adrenoleukodystrophy Fibroblasts. Antioxidants (Basel). 2022;11: pubmed publisher
Li Q, Fadoul G, Ikonomovic M, Yang T, Zhang F. Sulforaphane promotes white matter plasticity and improves long-term neurological outcomes after ischemic stroke via the Nrf2 pathway. Free Radic Biol Med. 2022;193:292-303 pubmed publisher
Watzky M, Huard S, Juricek L, Dairou J, Chauvet C, Coumoul X, et al. Hexokinase 2 is a transcriptional target and a positive modulator of AHR signalling. Nucleic Acids Res. 2022;50:5545-5564 pubmed publisher
Xirouchaki C, Jia Y, McGrath M, Greatorex S, Tran M, Merry T, et al. Skeletal muscle NOX4 is required for adaptive responses that prevent insulin resistance. Sci Adv. 2021;7:eabl4988 pubmed publisher
Giovannucci T, Salomons F, Haraldsson M, Elfman L, Wickström M, Young P, et al. Inhibition of the ubiquitin-proteasome system by an NQO1-activatable compound. Cell Death Dis. 2021;12:914 pubmed publisher
Siegel D, Bersie S, Harris P, Di Francesco A, Armstrong M, Reisdorph N, et al. A redox-mediated conformational change in NQO1 controls binding to microtubules and α-tubulin acetylation. Redox Biol. 2021;39:101840 pubmed publisher
Sekiguchi M, Seki M, Kawai T, Yoshida K, Yoshida M, Isobe T, et al. Integrated multiomics analysis of hepatoblastoma unravels its heterogeneity and provides novel druggable targets. NPJ Precis Oncol. 2020;4:20 pubmed publisher
Chatterjee A, Kosmacek E, Shrishrimal S, McDonald J, Oberley Deegan R. MnTE-2-PyP, a manganese porphyrin, reduces cytotoxicity caused by irradiation in a diabetic environment through the induction of endogenous antioxidant defenses. Redox Biol. 2020;34:101542 pubmed publisher
Shrishrimal S, Chatterjee A, Kosmacek E, Davis P, McDonald J, Oberley Deegan R. Manganese porphyrin, MnTE-2-PyP, treatment protects the prostate from radiation-induced fibrosis (RIF) by activating the NRF2 signaling pathway and enhancing SOD2 and sirtuin activity. Free Radic Biol Med. 2020;152:255-270 pubmed publisher
Serafini M, Catanzaro M, Fagiani F, Simoni E, Caporaso R, Dacrema M, et al. Modulation of Keap1/Nrf2/ARE Signaling Pathway by Curcuma- and Garlic-Derived Hybrids. Front Pharmacol. 2019;10:1597 pubmed publisher
Petrillo S, D Amico J, La Rosa P, Bertini E, Piemonte F. Targeting NRF2 for the Treatment of Friedreich's Ataxia: A Comparison among Drugs. Int J Mol Sci. 2019;20: pubmed publisher
La Rosa P, Russo M, D Amico J, Petrillo S, Aquilano K, Lettieri Barbato D, et al. Nrf2 Induction Re-establishes a Proper Neuronal Differentiation Program in Friedreich's Ataxia Neural Stem Cells. Front Cell Neurosci. 2019;13:356 pubmed publisher
Jeong J, Ji S, Lee H, Hong S, Kim G, Park C, et al. Fermented Sea Tangle (Laminaria japonica Aresch) Suppresses RANKL-Induced Osteoclastogenesis by Scavenging ROS in RAW 264.7 Cells. Foods. 2019;8: pubmed publisher
Yim S, Clish C, Gladyshev V. Selenium Deficiency Is Associated with Pro-longevity Mechanisms. Cell Rep. 2019;27:2785-2797.e3 pubmed publisher
Peng J, Zhou F, Wang Y, Xu Y, Zhang H, Zou F, et al. Differential response to lead toxicity in rat primary microglia and astrocytes. Toxicol Appl Pharmacol. 2018;363:64-71 pubmed publisher
Wang Y, Feng F, Liu M, Xue J, Huang H. Resveratrol ameliorates sepsis-induced acute kidney injury in a pediatric rat model via Nrf2 signaling pathway. Exp Ther Med. 2018;16:3233-3240 pubmed publisher
Bricambert J, Alves Guerra M, Esteves P, Prip Buus C, Bertrand Michel J, Guillou H, et al. The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity. Nat Commun. 2018;9:2092 pubmed publisher
Chen C, Chen Y, Sung P, Sun C, Chen K, Chen Y, et al. Effective protection against acute respiratory distress syndrome/sepsis injury by combined adipose-derived mesenchymal stem cells and preactivated disaggregated platelets. Oncotarget. 2017;8:82415-82429 pubmed publisher
Shrishrimal S, Kosmacek E, Chatterjee A, Tyson M, Oberley Deegan R. The SOD Mimic, MnTE-2-PyP, Protects from Chronic Fibrosis and Inflammation in Irradiated Normal Pelvic Tissues. Antioxidants (Basel). 2017;6: pubmed publisher
Petrillo S, Piermarini E, Pastore A, Vasco G, Schirinzi T, Carrozzo R, et al. Nrf2-Inducers Counteract Neurodegeneration in Frataxin-Silenced Motor Neurons: Disclosing New Therapeutic Targets for Friedreich's Ataxia. Int J Mol Sci. 2017;18: pubmed publisher
Simoni E, Serafini M, Caporaso R, Marchetti C, Racchi M, Minarini A, et al. Targeting the Nrf2/Amyloid-Beta Liaison in Alzheimer's Disease: A Rational Approach. ACS Chem Neurosci. 2017;8:1618-1627 pubmed publisher
Kim J, Lim J, Kang B, Jung K, Choi H. Capillarisin augments anti-oxidative and anti-inflammatory responses by activating Nrf2/HO-1 signaling. Neurochem Int. 2017;105:11-20 pubmed publisher
Zhang T, Hu Q, Shi L, Qin L, Zhang Q, Mi M. Equol Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice by Inhibiting Endoplasmic Reticulum Stress via Activation of Nrf2 in Endothelial Cells. PLoS ONE. 2016;11:e0167020 pubmed publisher
Qin T, Yin S, Yang J, Zhang Q, Liu Y, Huang F, et al. Sinomenine attenuates renal fibrosis through Nrf2-mediated inhibition of oxidative stress and TGF? signaling. Toxicol Appl Pharmacol. 2016;304:1-8 pubmed publisher
Qin T, Du R, Huang F, Yin S, Yang J, Qin S, et al. Sinomenine activation of Nrf2 signaling prevents hyperactive inflammation and kidney injury in a mouse model of obstructive nephropathy. Free Radic Biol Med. 2016;92:90-99 pubmed publisher
Boušová I, Bártíková H, Matoušková P, Lněničková K, Zappe L, Valentová K, et al. Cranberry extract-enriched diets increase NAD(P)H:quinone oxidoreductase and catalase activities in obese but not in nonobese mice. Nutr Res. 2015;35:901-9 pubmed publisher
Qin S, Du R, Yin S, Liu X, Xu G, Cao W. Nrf2 is essential for the anti-inflammatory effect of carbon monoxide in LPS-induced inflammation. Inflamm Res. 2015;64:537-48 pubmed publisher
Suyama K, Watanabe M, Sakabe K, Otomo A, Okada Y, Terayama H, et al. GRP78 suppresses lipid peroxidation and promotes cellular antioxidant levels in glial cells following hydrogen peroxide exposure. PLoS ONE. 2014;9:e86951 pubmed publisher
Zhang T, Liang X, Shi L, Wang L, Chen J, Kang C, et al. Estrogen receptor and PI3K/Akt signaling pathway involvement in S-(-)equol-induced activation of Nrf2/ARE in endothelial cells. PLoS ONE. 2013;8:e79075 pubmed publisher
Wang B, Zhu X, Kim Y, Li J, Huang S, Saleem S, et al. Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. Free Radic Biol Med. 2012;52:928-36 pubmed publisher
Gao M, Singh A, Macri K, Reynolds C, Singhal V, Biswal S, et al. Antioxidant components of naturally-occurring oils exhibit marked anti-inflammatory activity in epithelial cells of the human upper respiratory system. Respir Res. 2011;12:92 pubmed publisher
Solis L, Behrens C, Dong W, Suraokar M, Ozburn N, Moran C, et al. Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features. Clin Cancer Res. 2010;16:3743-53 pubmed publisher
Li C, Kim M, Godoy L, Thiantanawat A, Trudel L, Wogan G. Nitric oxide activation of Keap1/Nrf2 signaling in human colon carcinoma cells. Proc Natl Acad Sci U S A. 2009;106:14547-51 pubmed publisher
Salama S, Kamel M, Diaz Arrastia C, Xu X, Veenstra T, Salih S, et al. Effect of tumor necrosis factor-alpha on estrogen metabolism and endometrial cells: potential physiological and pathological relevance. J Clin Endocrinol Metab. 2009;94:285-93 pubmed publisher
Cho H, Imani F, Miller DeGraff L, Walters D, Melendi G, Yamamoto M, et al. Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease. Am J Respir Crit Care Med. 2009;179:138-50 pubmed publisher
Lee J, Bhora F, Sun J, Cheng G, Arguiri E, Solomides C, et al. Dietary flaxseed enhances antioxidant defenses and is protective in a mouse model of lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol. 2008;294:L255-65 pubmed
Dehn D, Siegel D, Zafar K, Reigan P, Swann E, Moody C, et al. 5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo. Mol Cancer Ther. 2006;5:1702-9 pubmed
Slitt A, Cherrington N, Dieter M, Aleksunes L, Scheffer G, Huang W, et al. trans-Stilbene oxide induces expression of genes involved in metabolism and transport in mouse liver via CAR and Nrf2 transcription factors. Mol Pharmacol. 2006;69:1554-63 pubmed
Zhang J, Schulz W, Li Y, Wang R, Zotz R, Wen D, et al. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. Carcinogenesis. 2003;24:905-9 pubmed
Anwar A, Dehn D, Siegel D, Kepa J, Tang L, Pietenpol J, et al. Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems. J Biol Chem. 2003;278:10368-73 pubmed
Siegel D, Anwar A, Winski S, Kepa J, Zolman K, Ross D. Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1. Mol Pharmacol. 2001;59:263-8 pubmed
Siegel D, Ross D. Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues. Free Radic Biol Med. 2000;29:246-53 pubmed
product information
master code :
NB200-209
SKU :
NB200-209
product name :
NQO-1 Antibody (A180) - BSA Free
unit size :
0.1 ml (also 0.025 ml)
description :
The NQO-1 Antibody (A180) - BSA Free from Novus is a mouse monoclonal antibody to NQO-1. This antibody reacts with canine,human,mouse,primate,rat. The NQO-1 Antibody (A180) - BSA Free has been validated for the following applications: IF/IHC,Immunoprecipitation,Western Blot,Immunohistochemistry-Paraffin,Immunocytochemistry/ Immunofluorescence,Flow Cytometry,Immunohistochemistry,Immunohistochemistry-Frozen,Flow (Intracellular),Simple Western.
target :
NQO-1
category :
Primary Antibodies
buffer :
PBS
clonality :
Monoclonal
clone :
A180
concentration :
1.0 mg/ml
conjugate :
Unconjugated
host :
Mouse
immunogen :
Full length recombinant NQO1 from human lung [UniProt# P15559]
isotype :
IgG1
purity :
Protein G purified
species :
Canine,Human,Mouse,Primate,Rat
specificity :
Does not cross-react with NQO2
theoretical molecular weight :
31 kDa
gene symbol :
NQO1
Antibody validation :
Biological Validation
applications :
IF/IHC,Immunoprecipitation,Western Blot,Immunohistochemistry-Paraffin,Immunocytochemistry/ Immunofluorescence,Flow Cytometry,Immunohistochemistry,Immunohistochemistry-Frozen,Flow (Intracellular),Simple Western
USD :
409 USD
alt names :
Azoreductase, DHQU, DIA4azoreductase, diaphorase (NADH/NADPH) (cytochrome b-5 reductase), dioxin-inducible 1, DTDEC 1.6.5.2, DT-diaphorase, Menadione reductase, NAD(P)H dehydrogenase [quinone] 1, NAD(P)H dehydrogenase, quinone 1, NAD(P)H:menadione oxidoreductase 1, NAD(P)H:Quinone acceptor oxidoreductase type 1, NAD(P)H:quinone oxidoreductase 1, NAD(P)H:quinone oxireductase, NMOR1diaphorase-4, Phylloquinone reductase, QR1NMORI, Quinone reductase 1
storage :
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
more info or order :
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.